Infections

LATEST NEWS

Postoperative Infection With Risk for Long-Term Infection and Mortality

By

Bradley van Paridon

Data published in JAMA Surgery showed that patients with 30-day postoperative infection had a 3.2-fold higher risk for 1-year infection and a 1.9-fold higher risk for mortality compared with those with no infections.

Varicella Strain Identity in First and Second Herpes Zoster Infection Episodes

By

Bradley van Paridon

Varicella zoster virus (VZV) is extremely stable during the varicella replication phase and subsequent establishment of latency in sensory ganglia throughout the body.

Household Environment Plays Role in MRSA Acquisition

Frequent handwashing may reduce likelihood of novel strain introduction into the household

Social Risk Factors Associated With Post-Colectomy Surgical Site Infections

By

Zahra Masoud

Infection prevention programs targeting low-income groups undergoing colectomy may be important in reducing surgical site infections.

Antimicrobial Resistance Patterns Examined for Adult, Pediatric HAIs

The researchers found that the three most frequently reported pathogens were Escherichia coli, Staphylococcus aureus, and Klebsiella spp.

Risk for Skin Infections May Be Increased With Statin Use

Using statins for as short a time as three months can put patients at risk for developing diabetes and skin and soft tissue infections.

Update on Efficacy of Treatments for Cutaneous Candidiasis

By

Linda Peckel

A review finds that fluconazole is the only commercially available evidence-based option for systemic treatment of cutaneous candidiasis.

Early Postop Infection Increases 1-Year Infection, Mortality Risk

Patients with 30-day postoperative infection have an increased risk for long-term infection and mortality.

Deep Surgical Site Infection After Knee Fracture Repair

By

Zahra Masoud

Orthopedic surgeons should be vigilant when managing periarticular knee fracture repairs.

Once-Daily Omadacycline Noninferior to Twice-Daily Linezolid for ABSSSI in Adults

By

Sweta Gupta

Once-daily oral omadacycline was noninferior to twice-daily oral linezolid in adults with acute bacterial skin and skin structure infections.